Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Umecrine Cognition

Umecrine Cognition
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.96M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of drugs against neurological disorders in the central nervous system designed to treat brain disorders. The company's pharmaceutical products focuses on finding treatments for neurological disorders in the central nervous system that are caused by endogenous CNS-active steroids (GABA-steroids), enabling healthcare industries to provide treatment that directly addresses the neurocognitive signs and symptoms of Hepatic encephalopathy (HE).

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2
  • 171 65 Solna
  • Sweden

+46 08-524 000 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Umecrine Cognition’s full profile, request a free trial.

Umecrine Cognition Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 22-Nov-2016 $4.96M 00.000 Completed Clinical Trials - General
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Umecrine Cognition Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Almi Invest Venture Capital Minority 000 0000 000000 0
Fort Knox Förvaring Holding Company Minority 000 0000 000000 0
Karolinska Development Venture Capital Minority 000 0000 000000 0
Norrlandsfonden Lender/Debt Provider Minority 000 0000 000000 0
Partnerinvest Norr Venture Capital Minority 000 0000 000000 0

Umecrine Cognition Executive Team (2)

Name Title Board
Seat
Contact
Info
Magnus Doverskog Ph.D Chief Executive Officer
Torbjörn Bäckström MD Chief Scientific Officer & Board Member

Umecrine Cognition Board Members (7)

Name Representing Role Since Contact
Info
Andersen Blom Self Board Member 000 0000
Bruce Scharschmidt Ph.D Umecrine Cognition Board Member 000 0000
Kenth Bergström Umecrine Cognition Chairman 000 0000
Terje Kalland Ph.D Self Board Member 000 0000
Tomas Odergren Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »